| Coral Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524506 |
NSE Symbol : - |
P/E(TTM) : 12.42 |
|
ISIN Demat : INE683E01017 |
Div & Yield% : 0.36 |
EPS(TTM) : 45.27 |
|
Book Value(₹) : 585.74 |
Market Cap(₹Cr) : 200.74 |
Face Value(₹) : 10.00 |
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 26.48 | 21.56 | 19.03 | 18.82 | 28.13 | 22.99 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 26.48 | 21.56 | 19.03 | 18.82 | 28.13 | 22.99 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 2.65 | 2.49 | 3.03 | 2.05 | 2.48 | 2.52 |
| Total Income | 29.13 | 24.06 | 22.07 | 20.87 | 30.62 | 25.51 |
| Total Expenditure | 20.29 | 19.67 | 14.10 | 16.64 | 26.22 | 16.67 |
| PBIDT | 8.84 | 4.38 | 7.97 | 4.23 | 4.40 | 8.84 |
| Interest | 0.01 | 0.00 | 0.10 | 0.06 | 0.04 | 0.02 |
| PBDT | 8.83 | 4.38 | 7.87 | 4.17 | 4.36 | 8.82 |
| Depreciation | 0.54 | 0.69 | 0.45 | 0.45 | 0.51 | 0.50 |
| Tax | 2.14 | 0.90 | 1.59 | 1.15 | 1.10 | 2.15 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.92 | 0.02 | 0.01 | 0.01 | -0.08 | 0.02 |
| Reported Profit After Tax | 5.22 | 2.78 | 5.82 | 2.56 | 2.83 | 6.14 |
| Extra-ordinary Items | -0.01 | 0.00 | 0.25 | 0.00 | -0.55 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 5.23 | 2.78 | 5.57 | 2.56 | 3.38 | 6.14 |
| EPS (Unit Curr.) | 14.62 | 7.77 | 16.29 | 7.18 | 7.91 | 17.20 |
| EPS (Adj) (Unit Curr.) | 14.62 | 7.77 | 16.29 | 7.18 | 7.91 | 17.20 |
| Calculated EPS (Unit Curr.) | 14.62 | 7.77 | 16.29 | 7.18 | 7.91 | 17.20 |
| Calculated EPS (Adj) (Unit Curr.) | 14.62 | 7.77 | 16.29 | 7.18 | 7.91 | 17.20 |
| Calculated EPS (Ann.) (Unit Curr.) | 58.49 | 31.08 | 65.16 | 28.71 | 31.65 | 68.80 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 58.49 | 31.08 | 65.16 | 28.71 | 31.65 | 68.80 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 3.57 | 3.57 | 3.57 | 3.57 | 3.57 | 3.57 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 33.38 | 20.32 | 41.88 | 22.48 | 15.64 | 38.45 |
| PBDTM(%) | 33.35 | 20.32 | 41.36 | 22.16 | 15.50 | 38.36 |
| PATM(%) | 19.71 | 12.89 | 30.58 | 13.60 | 10.06 | 26.71 |
